Title: Gemcitabine as a Single Agent in the Treatment
of Relapsed or Refractory Aggressive Non-Hodgkin's
Lymphoma Abstract: Nazionale Tumori, Milano, Italy. Address reprint
requests to A. Fosså, MD, PhD, Department of Immunology, The Norwegian
Radium Hospital, Montebello, 0310 Oslo, Norway; email alexanfo@labmed.uio.no.